This inventor holds 33 USPTO granted patents and 33 published patent applications, primarily in Pharmaceutical Compositions. Top assignees: Slayback Pharma LLC, Azurity Pharmaceuticals, Inc., Ani Pharmaceuticals, Inc.. Active years: 2022-2026.
Location History:
- Hyderabad, IN (2022 - 2024)
- Telangana, IN (2023 - 2024)
Company Filing History:
25 out of 40Â 
4 out of 51Â 
3 out of 10Â Years Active: 2022-2026
Areas of Expertise:
Title: Sumitra Ashokkumar Pillai: Innovator in Pharmaceutical Advancements
Introduction: Sumitra Ashokkumar Pillai is an accomplished inventor based in Hyderabad, Telangana, India, known for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 22 patents, he is dedicated to creating stable and efficient drug formulations that address various medical needs.
Latest Patents: Sumitra's latest patents showcase his expertise in developing stable pharmaceutical compositions. One noteworthy invention is a stable liquid formulation of clonidine, which is designed for oral administration and stability over extended periods. This formulation is particularly significant for conditions treatable by clonidine, ensuring effective therapy through reliable medicinal use. Another impressive patent includes stable pharmaceutical compositions of apixaban, which encompasses a capsule formulation containing a therapeutically effective amount of apixaban. This invention emphasizes the importance of stable compositions for the prevention and treatment of relevant disorders.
Career Highlights: Throughout his career, Sumitra Ashokkumar Pillai has been associated with leading companies in the pharmaceutical industry, such as Slayback Pharma and Ani Pharmaceuticals. His work at these institutions has greatly contributed to the understanding and application of pharmaceutical compositions, thereby impacting patient care significantly.
Collaborations: Collaboration has been a vital aspect of Sumitra's journey as an inventor. He has worked closely with professionals such as Sushant Omprakash Dube and Pankaj Kisan Chatki, further enriching his research and innovation efforts in the pharmaceutical domain.
Conclusion: Sumitra Ashokkumar Pillai remains a prominent figure in pharmaceutical innovation, exemplified by his 22 patents that continually push the boundaries of drug formulation technology. His latest work in stable pharmaceutical compositions, combined with his collaborative efforts, positions him as a key contributor to advancements in medication stability and effectiveness.